# Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

> **NCT06812598** · NA · RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 330 (estimated)

## Conditions studied

- Cytomegalovirus Infections
- CMV

## Interventions

- **DRUG:** Letermovir (0-24w）
- **DRUG:** Letermovir (0-14w）

## Key facts

- **NCT ID:** NCT06812598
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06812598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06812598, "Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06812598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*